Management of Pemphigus in COVID-19 Pandemic Era; a Review Article

The novel coronavirus is rapidly spreading around the world. since the public announcement of the covid-19 outbreak, several concerns have been raised by dermatologists as well as pemphigus patients who take immunosuppressive drugs. in this paper, we review the literature about the common treatment of pemphigus with a focus on the lessons from similar epidemics to find a proper suggestion to manage pemphigus in the covid-19 pandemic era. the effect of many of the drugs used for treatment of pemphigus vulgaris (pv) on covid-19 is not clear. we also do not have data on the impact of this autoimmune disease, which may involve the mucous membranes, on the acquisition or course of covid-19. we are currently in the midst of a pandemic and evaluating the effect of covid-19 on the population of susceptible patients suffering from auto-immune diseases like pemphigus is essential. the evidence on best ways to manage patients with underlying conditions, such as pemphigus, during the outbreak of covid-19 is evolving and the data is updated every day.